Since then, deregulated TDP-43 has been described in several neurodegenerative diseases with different degrees of penetration, from ALS (97%) to FTD (45–50%) to Alzheimer’s disease (AD, 40–50%) (as reviewed in [9]). Here, TARDBP is linked to frontotemporal dementia.